<?xml version="1.0" encoding="UTF-8"?><rss
version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
> <channel><title>Comments on: Genentech Submits Supplemental Biologics License Application for ACTEMRA (tocilizumab) for Prevention of Structural Joint Damage and Improvement of Physical Function in Rheumatoid Arthritis</title> <atom:link href="http://www.ttkn.com/health/genentech-submits-supplemental-biologics-license-application-for-actemra-tocilizumab-for-prevention-of-structural-joint-damage-and-improvement-of-physical-function-in-rheumatoid-arthritis-897.html/feed/" rel="self" type="application/rss+xml" /><link>http://www.ttkn.com/health/genentech-submits-supplemental-biologics-license-application-for-actemra-tocilizumab-for-prevention-of-structural-joint-damage-and-improvement-of-physical-function-in-rheumatoid-arthritis-897.html/</link> <description>News from around the world - First</description> <lastBuildDate>Fri, 24 Jun 2011 12:15:35 +0000</lastBuildDate> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <generator>http://wordpress.org/?v=3.3</generator> </channel> </rss>
